Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2026

The following Common Stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:

Schedule of Anti-dilutive Securities

	June 30, 2026 (Unaudited)		June 30, 2025 (Unaudited)
Series L Preferred Stock ¹		1,404,651		3,084,382
Options to purchase Common Stock		597,550		124,600
Warrants to purchase Common Stock		57,551,105		16,751,669
Total anti-dilutive securities		59,553,306		19,960,651

¹	As of June 30, 2026, the shares are convertible into shares of Common Stock at the holder’s option using a conversion price of $0.454 per share.